September 11th, 2014
Boback Ziaeian discusses his observational study exploring the benefits of guideline-recommended cardiac resynchronization therapy and ICD therapy in heart failure patients, according to race and ethnicity.
August 25th, 2014
A 57-year-old woman with paroxysmal atrial fibrillation, long-QT syndrome after ICD implantation, and severe anxiety presents a unique diagnostic challenge.
July 17th, 2014
Reimbursement issues might add a layer of complexity to the findings from the SIMPLE trial.
June 3rd, 2014
Implantable cardioverter-defibrillators are routinely implanted in heart failure patients with ejection fractions of 35% and lower to prevent sudden cardiac death. However, the benefits in patients at the higher end of the spectrum — EFs between 30% and 35% — have not been well demonstrated in clinical trials, since few patients in this range have […]
May 12th, 2014
This week’s topic is the influence of healthy candidate bias when assessing clinical effectiveness for ICDs.
May 9th, 2014
Although commonly performed, routine defibrillation testing has never been shown to be safe or necessary. Now a new study, presented yesterday at the Heart Rhythm Society meeting in San Francisco, offers evidence that although routine testing is generally safe it may increase complications without producing any improvement in outcomes. In the SIMPLE (Shockless Implant Evaluation) trial, sponsored by Boston […]
April 8th, 2014
Promporn Suksaranjit provides an update on the safety of pacemakers and ICDs in an MRI environment.
March 28th, 2014
Edward J. Schloss reflects on the release of the new Optisure family of ICD leads by St. Jude Medical, as well as the history of leads made by this company.
March 3rd, 2014
Anna Catino presents our latest case: A young, male, long-distance runner experiencing palpitations, who has lamin A/C deficiency and a family history of cardiac disease. How would you manage this patient?
February 3rd, 2014
This week’s topics include biomarkers for systemic sclerosis, the effectiveness of ICDs for primary prevention of sudden cardiac death, and more.